铁死亡在神经胶质瘤治疗中的作用

doi:10.3760/cma.j.issn.1007-1245.2022.17.003

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (17): 2383-2385.DOI: 10.3760/cma.j.issn.1007-1245.2022.17.003

铁死亡在神经胶质瘤治疗中的作用

王宁宁朱淑霞张越华

滨州医学院附属医院儿童神经科　256600

收稿日期:2022-04-29 出版日期:2022-09-01 发布日期:2022-10-11
通讯作者: 朱淑霞，Email：zhusx2003@163.com
基金资助:
山东省中医药科技发展项目（2019-0516）

Role of ferroptosis in treatment of glioma

Wang Ningning, Zhu Shuxia, Zhang Yuehua

Department of Pediatric Neurology, Hospital Affiliated to Binzhou Medical Univercity, Binzhou 256600, China

Received:2022-04-29 Online:2022-09-01 Published:2022-10-11
Contact: Zhu Shuxia, Email: zhusx2003@163.com
Supported by:
Project for Development of Science and Technology of Traditional Chinese Medicine in Shandong (2019-0516)

摘要/Abstract

摘要： 铁死亡是一种铁依赖性脂质过氧化物损伤诱导的调节性细胞死亡形式，其在分子生物学、形态学和遗传学等方面都不同于凋亡、自噬和坏死等细胞死亡形式。铁死亡在神经胶质瘤的治疗中发挥重要作用，诱导胶质瘤细胞铁死亡将成为治疗肿瘤的新策略。本文对铁死亡的相关基因xCT、Nox4、NCOA4、BECN1在神经胶质瘤治疗中的作用及中药在神经胶质瘤中对铁死亡的治疗作用进行阐述，以期为神经胶质瘤的临床治疗提供新方向和新思路。

关键词: 铁死亡, 神经胶质瘤, 基因

Abstract: Ferroptosis is a form of regulated cell death induced by iron-dependent lipid peroxide damage, and it is different from apoptosis, autophagy, and necrosis in molecular biology, morphology, and genetics. It plays an important role in the treatment of glioma, and induction of ferroptosis in glioma cells will become a new strategy for anti-tumor therapy. This article expounds the role of ferroptosis related genes, xCT, Nox4, NCOA4, and BECN1, in the treatment of glioma and the therapeutic effect of traditional Chinese medicine on ferroptosis in glioma, so as to provide new directions and ideas for the clinical treatment of glioma.

Key words: Ferroptosis, Glioma, Gene

王宁宁朱淑霞张越华. 铁死亡在神经胶质瘤治疗中的作用[J]. 国际医药卫生导报, 2022, 28(17): 2383-2385.

Wang Ningning, Zhu Shuxia, Zhang Yuehua. Role of ferroptosis in treatment of glioma[J]. International Medicine and Health Guidance News, 2022, 28(17): 2383-2385.

参考文献

[1] Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary [J]. Acta Neuropathol, 2016, 131(6): 803-820. DOI: 10.1007/s00401-016-1545-1.
[2] Liu HJ, Hu HM, Li GZ, et al. Ferroptosis-related gene signature predicts glioma cell death and glioma patient progression [J]. Front Cell Dev Biol, 2020, 8:538. DOI: 10.3389/fcell.2020.00538.
[3] Ostrom QT, Patil N, Cioffi G, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united states in 2013-2017 [J]. Neuro Oncol, 2020, 22 12 Suppl 2: iv1-iv96. DOI: 10.1093/neuonc/noaa200.
[4] Cao JY, Dixon SJ. Mechanisms of ferroptosis [J]. Cell Mol Life Sci, 2016, 73(11-12): 2195-2209. DOI: 10.1007/s00018-016-2194-1.
[5] Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy [J]. Protein Cell, 2021, 12(8): 599-620. DOI: 10.1007/s13238-020-00789-5.
[6] Habib E, Linher-Melville K, Lin HX, et al. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress [J]. Redox Biol, 2015, 5: 33-42. DOI: 10.1016/j.redox.2015.03.003.
[7] Fan Z, Wirth AK, Chen D, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis [J]. Oncogenesis, 2017, 6(8):e371. DOI: 10.1038/oncsis. 2017.65.
[8] Chen D, Rauh M, Buchfelder M, et al. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas [J]. Oncotarget, 2017, 8(31): 51164-51176. DOI: 10.18632/oncotarget.17737.
[9] Panieri E, Buha A, Telkoparan-Akillilar P, et al. Potential applications of NRF2 modulators in cancer therapy [J]. Antioxidants (Basel), 2020, 9(3): 193. DOI: 10.3390/antiox9030193.
[10] Liu ML, Sun D, Li T, et al. A systematic review of the immune-regulating and anticancer activities of pseudolaric acid B [J]. Front Pharmacol, 2017, 8:394. DOI: 10.3389/fphar.2017.00394.
[11] Yu J, Wang Z, Ren P, et al. Pseudolaric acid B inhibits the secretion of hepatitis B virus [J]. Oncol Rep, 2017, 37(1):519-525. DOI: 10.3892/or.2016.5254.
[12] Song F, Yu X, Zhang H, et al. Pseudolaric acid B inhibits neuroglioma cell proliferation through DNA damage response [J]. Oncol Rep, 2017, 38(4): 2211-2218. DOI: 10.3892/or.2017.5861.
[13] Wang Z, Ding Y, Wang X, et al. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT [J]. Cancer Lett, 2018, 428: 21-33. DOI: 10.1016/j.canlet.2018.04.021.
[14] Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer [J]. Cancer Cell, 2019, 35(6): 830-849. DOI: 10.1016/j.ccell.2019.04.002.
[15] Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process [J]. Cell Res, 2016, 26(9): 1021-1032. DOI: 10.1038/cr.2016.95.
[16] Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease [J]. Cell, 2017, 171(2): 273-285. DOI: 10.1016/j.cell.2017.09.021.
[17] Fuhrmann DC, Mondorf A, Beifuß J, et al. Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis [J]. Redox Biol, 2020, 36: 101670. DOI: 10.1016/j.redox.2020.101670.
[18] Mancias JD, Wang X, Gygi SP, et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy [J]. Nature, 2014, 509(7498):105-109. DOI: 10.1038/nature13148.
[19] Beck R, Rawet M, Wieland FT, et al. The COPI system: molecular mechanisms and function [J]. FEBS Lett, 2009, 583(17): 2701-2709. DOI: 10.1016/j.febslet.2009.07.032.
[20] Zhang Y, Kong Y, Ma Y, et al. Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines [J]. Oncogene, 2021, 40(8): 1425-1439. DOI: 10.1038/s41388-020-01622-3.
[21] Miracco C, Cosci E, Oliveri G, etal. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours [J]. Int J Oncol, 2007, 30(2): 429-436.
[22] Tamrakar S, Yashiro M, Kawashima T, et al. Clinicopathological significance of autophagy-related proteins and its association with genetic alterations in gliomas [J]. Anticancer Res, 2019, 39(3): 1233-1242. DOI: 10.21873/anticanres.13233.
[23] Escamilla-Ramírez A, Castillo-Rodríguez RA, Zavala-Vega S, et al. Autophagy as a potential therapy for malignant glioma [J]. Pharmaceuticals (Basel), 2020, 13(7): 156. DOI: 10.3390/ph13070156.
[24] Kang R, Zhu S, Zeh HJ, et al. BECN1 is a new driver of ferroptosis [J]. Autophagy, 2018, 14(12): 2173-2175. DOI: 10.1080/15548627.2018.1513758.
[25] Song X, Zhu S, Chen P, et al. AMPK-mediated becn1 phosphorylation promotes ferroptosis by directly blocking system Xc-activity [J]. Curr Biol, 2018, 28(15): 2388-2399.e5. DOI: 10.1016/j.cub.2018.05.094.
[26] Zhang Z, Yao Z, Wang L, et al. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells [J]. Autophagy, 2018, 14(12): 2083-2103. DOI: 10.1080/15548627.2018.1503146.
[27] Efferth T. From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy [J]. Semin Cancer Biol, 2017, 46: 65-83. DOI: 10.1016/j.semcancer. 2017.02.009.
[28] Greenshields AL, Fernando W, Hoskin DW. The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells [J]. Exp Mol Pathol, 2019, 107:10-22. DOI: 10.1016/j.yexmp.2019. 01.006.
[29] Lin R, Zhang Z, Chen L, et al. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells [J]. Cancer Lett, 2016, 381(1): 165-175. DOI: 10.1016/j.canlet.2016.07.033.

铁死亡在神经胶质瘤治疗中的作用

Role of ferroptosis in treatment of glioma

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

[1]	尹伟明, 卢小娟, 张旭明. UGT1A1基因多态性对宝安地区女性妊娠期甲状腺功能减退的临床价值[J]. 国际医药卫生导报, 2022, 28(9): 1263-1266.
[2]	梅佳慧, 娄焕堃, 王勋, 韩翠敏, 李鹏, 邢团结, 汪明琅, 王怡练. ApoE基因多态性与ADMA水平在慢性肾脏病患者中的关联研究 [J]. 国际医药卫生导报, 2022, 28(8): 1047-1052.
[3]	宋晓波, 吴婷婷, 李凡. 鹦鹉热衣原体肺炎2例并文献复习[J]. 国际医药卫生导报, 2022, 28(8): 1089-1092.
[4]	吴威, 谭永星, 王永旺. 肝移植围术期诱发肠损伤铁死亡的研究新进展[J]. 国际医药卫生导报, 2022, 28(7): 1025-1028.
[5]	张宪芬, 张殿宝, 韩婉青, 王永生. CYP2C19基因指导非体外循环冠脉旁路移植术后抗血小板治疗的意义[J]. 国际医药卫生导报, 2022, 28(4): 459-463.
[6]	李立巍. 探讨PCR技术于检验沙门菌中的应用与进展[J]. 国际医药卫生导报, 2022, 28(3): 368-370.
[7]	宋鹏程祝晓娜高祥敬鞠莎李飞. EGFR、ALK双突变非小细胞肺癌1例[J]. 国际医药卫生导报, 2022, 28(18): 2627-2630.
[8]	钟瑜明方晓丽张相军宋萍. Shprintzen-Goldberg综合征1例报道并文献复习[J]. 国际医药卫生导报, 2022, 28(16): 2284-2287.
[9]	王宁宁朱淑霞. microRNA-137在神经胶质瘤中的作用机制[J]. 国际医药卫生导报, 2022, 28(13): 1916-1919.
[10]	程金凤, 王倩倩, 甄萌萌, 程艳丽. 生物钟基因Cry1与动脉粥样硬化相关性研究进展[J]. 国际医药卫生导报, 2022, 28(10): 1343-1346.
[11]	伏红霞, 傅永旺, 李攀. CYP2C19基因多态性与呼和浩特地区急性脑梗死氯吡格雷抵抗的相关性分析[J]. 国际医药卫生导报, 2022, 28(1): 11-14.